Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,418,000 | 2,230,000 | 1,289,000 | 4,286,000 | 4,309,000 |
| Depreciation Amortization | 6,999,000 | 4,089,000 | 2,039,000 | 8,386,000 | 6,284,000 |
| Income taxes - deferred | -107,000 | -300,000 | -28,000 | -1,449,000 | -682,000 |
| Accounts receivable | -1,652,000 | -1,496,000 | -1,479,000 | 207,000 | -180,000 |
| Accounts payable and accrued liabilities | 1,549,000 | -181,000 | -696,000 | 177,000 | -1,070,000 |
| Other Working Capital | -1,889,000 | -3,046,000 | -2,563,000 | -2,845,000 | -2,385,000 |
| Other Operating Activity | 6,494,000 | 5,492,000 | 3,073,000 | 10,044,000 | 5,482,000 |
| Operating Cash Flow | $13,812,000 | $6,788,000 | $1,635,000 | $18,806,000 | $11,758,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -885,000 | -504,000 | -235,000 | -974,000 | -683,000 |
| Net Acquisitions | -4,280,000 | -1,478,000 | -538,000 | -20,517,000 | -18,725,000 |
| Purchase Of Investment | -29,000 | -22,000 | -10,000 | -73,000 | -46,000 |
| Sale Of Investment | 42,000 | 39,000 | 32,000 | 555,000 | 516,000 |
| Other Investing Activity | -28,000 | 49,000 | 16,000 | 189,000 | -8,000 |
| Investing Cash Flow | $-5,180,000 | $-1,916,000 | $-735,000 | $-20,820,000 | $-18,946,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 5,797,000 | 5,556,000 | 1,593,000 | 5,008,000 | 5,008,000 |
| Debt Issued | 3,994,000 | 3,994,000 | 3,994,000 | 16,963,000 | 14,963,000 |
| Debt Repayment | -6,789,000 | -6,780,000 | -3,026,000 | -9,613,000 | -3,851,000 |
| Common Stock Issued | 124,000 | 61,000 | 56,000 | 214,000 | 204,000 |
| Common Stock Repurchased | -977,000 | -973,000 | -961,000 | -1,708,000 | -1,350,000 |
| Dividend Paid | -8,746,000 | -5,835,000 | -2,925,000 | -11,025,000 | -8,273,000 |
| Other Financing Activity | -1,961,000 | 9,000 | 11,000 | -5,050,000 | -5,051,000 |
| Financing Cash Flow | $-8,558,000 | $-3,968,000 | $-1,258,000 | $-5,211,000 | $1,650,000 |
| Exchange Rate Effect | 31,000 | 39,000 | 9,000 | -65,000 | -19,000 |
| Beginning Cash Position | 5,524,000 | 5,524,000 | 5,524,000 | 12,814,000 | 12,814,000 |
| End Cash Position | 5,629,000 | 6,467,000 | 5,175,000 | 5,524,000 | 7,257,000 |
| Net Cash Flow | $105,000 | $943,000 | $-349,000 | $-7,290,000 | $-5,557,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 13,812,000 | 6,788,000 | 1,635,000 | 18,806,000 | 11,758,000 |
| Capital Expenditure | -885,000 | -504,000 | -235,000 | -974,000 | -683,000 |
| Free Cash Flow | 12,927,000 | 6,284,000 | 1,400,000 | 17,832,000 | 11,075,000 |